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Early Diagnosis and Management of Prostate 
Cancer 
EC. HAMDY 
Academic Urology Unit. Schoo/ of Medicine & Biomedica/ 
Sciences University of Sheffield, Sheffield, UK 
Prostate cancer is a significant cause of morbidity and mortality 
in the United States and Europe. It is the second most common 
cancer in men in the European Union, with 85,000 new cases 
and approximately 40,000 deaths each year. The natural 
ageing of the population, combined with the continued and 
widespread use of improved diagnostic tests such as serum 
prostate specific antigen (PSA), are resulting in an increase 
in the numbers of men diagnosed with Iocalised prostate 
cancer. Screening to identify organ-confined disease has 
provoked much public and scientific attention and there is 
intense debate about its role in improving men's health. W ile 
there are strong advocates of screening, the findings from most 
reviews of the scientific evidence conclude that it is insufficient, 
at present to recommend routine population screening because 
of the lack of evidence that this would improve survival and 
the quality of men's lives. Particular concerns in these reviews 
relate to the lack of knowledge about the natural history of 
screen-detected disease, and the lack of evidence about the 
effectiveness of treatments. 
In particular, to date, whilst the recent Scandinavian SPCG- 
IV randomized controlled trial of watchful waiting versus 
radical prostatectomy has demonstrated a survival benefit 
as well as reduced progression in men receiving surgery 
versus no treatment for clinically localized prostate cancer, no 
survival advantage has been shown to date in screen-detected 
cases for any of the major treatments (radical prostatectomy, 
radical radiotherapy including brachytherapy and "watchful 
waiting" otherwise known as "Active Monitoring" or "Active 
Surveillance with delayed intervention"). Each can result in 
damaging iatrogenic omplications and outcomes, including 
various levels of incontinence and impotence for radical 
interventions and anxiety relating to the presence of cancer 
in untreated patients. Furthermore, recent observations from 
the Prostate Cancer Prevention Trial in the US have revealed 
that the incidence of the disease is considerably higher than 
expected at low PSA levels, with a significant risk of over- 
detection and over-treatment in the majority of screen-detected 
cases. 
Despite these uncertainties, opportunistic screening for 
prostate cancer is widespread in many countries.Two 
randomised trials of screening are ongoing ; the Prostate 
Lung and Colorectal and Ovarian Trial (PLCO) in the USAand 
the European Randomised Screening for Prostate Cancer 
(ERSPC). There are two current trials of Iocalised prostate 
cancer treatments: the Prostate Testing for Cancer and 
Treatment study (ProtecT) in the UK and the Prostate Cancer 
Intervention Versus Observation Trial (PIVOT) in the USA. 
Whilst controversies persist in the management of localized 
disease, many advances have been made in the treatment 
of locally advanced, as well as metastatic prostate cancer. 
Improved technology and better understanding of the biology 
of prostate cancer have allowed new combination treatment 
strategies to be developed. Sophisticated radiotherapy 
combined with androgen suppression appear to improve 
survival in locally advanced disease, and fine tuning of 
interventions allow protection of the skeleton and improved 
palliation in metastatic and hormone refractory disease, using 
novel chemotherapeutic agents and bone resorption inhibitors 
such as bisphosphonates. 
There is a considerable paradigm shift in the general 
management strategy for prostate cancer, from the 
development of active monitoring programmes for low-risk 
tumours, to the conversion of previously debilitating advanced 
disease into a chronic, manageable condition with improved 
outcomes and quality of life for our patients. 
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S 02 S 03 
Microarray-based molecular profiling of advanced 
and hormone-refractory prostate cancer 
Role of estrogen receptor ~ in the pathogenesis 
and progression of prostate cancer 
M. WOLF, H. EDGREN, I. MILLS, A. CARLES, O. POCH, 
S. KILPINEN, M. PELTOLA, R. AUTIO, D. NEAL, B. 
WASYLYK, J. SCHALKEN, O. KALLIONIEMI 
EU FP6 PRIMA (Prostate Cancer Integral Management 
Approach) VTT Technical Research Centre of Finland and 
University of Turku, Finland; University of Cambridge, UK; 
/nstitut de Genetique et de Bio/ogie Mo/6cu/aire et 
Ce/lu/aire, ///kirch, France ; Tampere University of 
Technology, Tampere, Fin/and; Radboud University 
Nijmegen Medical Centre, The Netherlands 
There are few treatment options available for hormone- 
refractory and metastatic prostate cancer, largely as a result 
of incomplete understanding of the molecular mechanisms 
underlying the disease progression. In order to characterize 
clonal selection mechanisms leading to the failure of androgen 
deprivation therapy, we have analyzed a unique sample set 
of 19 advanced prostate cancers, consisting of hormone- 
refractory prostate cancers (HR-PRCA) and untreated 
advanced tumors using oligo-CGH and gene expression 
microarrays. In addition, publicly available existing gene 
expression data from normal prostate tissues and untreated 
prostate cancers were used as a reference to validate the 
relevance of the gene targets identified here. 
The genetic changes identified by oligo-CGH in the two groups 
were partly overlapping, but HR-PRCA also displayed many 
unique alterations (such as gains/amplifications at Xq12, 
lq21-q32, 2q31-q33, 3q21-q28 and deletions at 15q 14-q22 
and 15q24-25). A novel data integration method, DNA/RNA 
Outlier Analysis, was used to identify the targets genes for the 
genetic changes. Several outlier genes were identified as 
targets for genomic amplifications and deletions in both sample 
groups, such as AR as a target gene for Xq12 amplification 
in HR-PRCA, and PTEN as a target for 10q23 loss, as well 
as a several other novel genes at these and other loci. Based 
on all the identified outlier hits, Wnt signaling pathway showed 
the most significant enrichment in both sample groups 
indicating that deregulation of this critical pathway in prostate 
cancer occurs through genome-level alterations. 
In summary, we have applied here an integrative microarray 
based analysis on gene copy number and expression of 
advanced prostate cancers, which has led to the identification 
of several novel targets with putative relevance in hormone- 
refractory prostate cancers. Ongoing functional studies will 
further clarify their therapeutic potential. 
D. DONDI1, D. SAU 1, M. PICCOLELLA 1, 
M. TORTORETO3, G. PRATESI3, P. ClANA 2, A. MAGGI 2, 
V. GUERINI1, M. MOTTA1, A. POLETTI 1.. 
1 Institute of Endocrinology; 2 Department of 
Pharmacological Sciences, University of Milan, Milano, 
Italy, via Balzaretti 9, 20133 Milano, Italy. 3 Istituto 
Nazionale Tumori, Via Venezian, 1.20133 - Milano. *E-mail 
: angelo.poletti@unimi.it 
In earlier stages, prostate cancer (PC) depends on androgens 
and its growth can be usually controlled by androgen blockade. 
However, androgen-ablation therapy often induces androgen- 
independent PC, which is generally characterized by an 
increased invasiveness. Recently, we found that the 
testosterone derivative, dihydrotestosterone (DHT) inhibits 
PC cell migration through an androgen receptor (AR)- 
independent mechanism. This effect has been linked to the 
DHT metabolite 5alpha-androstane-3beta,17beta-diol (3beta- 
Adiol), which is unable to bind AR, but interacts with the 
estrogen receptor beta (ERbeta). 3beta-Adiol inhibits cell 
migration of PC cells through the activation of the ERbeta 
signaling, while, surprisingly, estradiol is not active, suggesting 
the existence of different pathways for ERbeta activation in 
PC cells. The inhibitory effects of 3beta-Adiol on PC cell 
migration appear to be mediated by an overexpression of E- 
cadherin, a protein known to be capable to reduce metastasis 
formation of breast cancer and PC cells. In fact, 3beta-Adiol 
is not active on PC cells in which E-cadherin expression has 
been silenced using a selective siRNA. 
To further investigate the growth properties of PC cells in 
vivo, we implanted DU145 cells stably transfected with AR 
(DU145-AR) and DU145-mock s.c. into nude male mice to 
characterize their receptor state. Tumor growth was followed 
up to 25 days. The DU145-mock xenografts kept an 
exponential growth in such time frame ; castration only 
marginally influenced tumor growth. Interestingly, testosterone 
seemed to be able to reduce the growth of the tumors 
generated by DU145-mock suggesting that an androgenic 
metabolite (3beta-Adiol ?) may be responsible for this effect. 
On the other hand, tumor growth of DU145-AR xenografts was 
significantly lower and further inhibited by androgen deprivation. 
After testosterone replacement, the growth rate was restored 
to that of DU145-AR xenografts in intact animals, suggesting 
that the molecular changes present in the stably transfected 
DU145-AR cells influence their growth properties in in vivo 
systems. 
The present data demonstrated that 1) testosterone may 
exert an estrogenic effects downstream in the catabolic 
process present in the prostate; 2) the estrogenic effect of 
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testosterone derivatives (ERbeta-dependent) inhibits cell 
migration, although it is apparently different from that linked 
to estradiol on the same receptor and may be protective 
against PC invasion and metastasis. These results correlate 
with the clinical data reporting that alterations in gene coding 
for 3beta-HSDs (the enzymes responsible for 3beta-Adiol 
formation) are strongly correlated with hereditary PC. 
S 04 
Benign prostatic hyperplasia - current 
management options and future prospects 
C. SCHULMAN 
Dept. Urology, Erasme Hospital, University Clinics of 
Brussels, route de Lennik 808, B-1070 Brussels, Belgium 
Email : claude.Schulman@ulb.ac.be 
No abstract provided. 
detection of first genes that are allow to distinguish very 
early seminomas from nonseminomas ;
discovery of new gene expression markers of rare germ 
cell tumours that do not originate from CIS (infantile tumours 
or spermatocytic seminomas of elderly men) ; 
discovery of new markers applicable for clinical diagnosis 
of CIS, including CIS cells found in semen samples, e.g. 
TFAP2C (AP2 gamma). 
Some of these findings are currently tested in clinical studies 
and begin to benefit patients. 
S 06 
Fetal androgen disruption and chronic adult germ 
cell apoptosis - a model for the testicular 
dysgenesis syndrome 
S 05 
Germ cell cancer : clinical applications of gene 
expression profiles 
M. BENAHMED 
Inserm U-407, Faculte de Medecine Lyon Sud, BP 12, 
69921 Oullins Cedex, France Email : 
benahmed@grisn, univ-lyon 1. fr 
No abstract provided. 
E. RAJPERT-DE MEYTS 
Department of Growth & Reproduction, Copenhagen 
University Hospital (Rigshospita/et), Denmark 
Recent years have seen an explosive increase in gene 
expression studies because of the availability of high- 
throughput methods, in particular microarrays (cDNA- or 
oligonucleotide- arrays). DNA chips - as the microarrays are 
popularly called - enable the investigator to evaluate relative 
expression of thousands of genes simultaneously in one 
experiment. This ingenious technology has provided 
researchers with an ocean of new information concerning 
global gene expression in many types of normal cells or 
tissues, and changes of their gene expression profiles in 
diseases, including cancer. The germ cell cancer research field 
has also benefited from these studies. Among the most 
important findings, to name just a few, are : 
high expression of pluripotency genes and stem-cell related 
factors in the pre-invasive carcinoma in situ (CIS) and 
embryonal carcinoma (EC) and EC-derived cell lines ; 
construction of new expression-based classifiers allowing 
to predict the predominant histological component of 
nonseminomatous tumours (nonseminomas) ;
S 07 
Fertility after testis cancer 
E. HUYGHE 
Human Fertility Research Group, HSpital Paule de Viguier, 
330Avenue de Grande Bretagne, 31059 TOULOUSE 
cedex 9, France 
Testicular cancer (TC) is the most common cancer in men 20 
to 35 years of age. Its prognosis is excellent and TC represents 
a model of curable cancer (cure rate exceeding 95%). For long- 
term survivors, often in the reproductive age, fertility 
preservation is a major preoccupation. 
Epidemiological, histological and clinical data point out a 
common aetiology between testicular germ cell cancer, male 
genital abnormalities (such as cryptorchidism) and conditions 
289 
related to male reproductive health (such as infertility). More 
than half of the patients with TC already have testicular 
impairment before orchiectomy. The degree of spermatogenic 
dysfunction is higher than what can be explained by local 
tumour effect and by a general cancer effect. Histological 
abnormalities are frequently observed in the controlateral 
testis. 
Treatments such as cytotoxic chemotherapies and 
radiotherapy are associated with significant gonadal damage 
in men. Cisplatin-based chemotherapy for TC results in 
temporary azoospermia in most men, with a recovery of 
spermatogenesis in about 50% of the patients after 2 years 
and 80% after 5 years. A cumulative dose of cisplatin at 400 
mg/m2 is predictive of the occurrence of long-term effects 
on sperm production. Second line chemotherapies may contain 
alkylating agents that are damaging agents for 
spermatogenesis. 
The germinal epithelium is very sensitive to radiation-induced 
damage: Testicular doses of less than 0.2 Gy have no 
significant effect on FSH levels and sperm counts. Doses 
above 0.2 lead to a dose-dependent increase in FSH and 
reduction in sperm concentration. The time to recovery, if it 
occurs, is likely to be dose dependent. It is considered that 
doses of 1.2 Gy and above are at high risk of definitive 
impairment of spermatogenesis. Limitation of the radiation field 
to the para-aortic field, total radiation dose less than 30 Gy 
and testicular shielding are ways to limit radiation-induced 
impairment of fertility. 
Information and counselling about semen cryopreservation, 
chance of recovery of spermatogenesis and current available 
methods of ART are mandatory. Cryopreservation of 
spermatozoa is a simple and practical approach to preserve 
fertilizing potential, and its proposal is part of good clinical 
practice. Wait-and-see strategies and ways to decrease 
morbidity of treatments should be strongly promoted and 
prospective trials comparing patients with and without cytotoxic 
treatment should be developed to ascertain the extent to 
which treatment affects long-term fertility. Cooperation between 
oncologists, urologists and andrologists on this topic remains 
essential. 
abnormalities with recorded frequency of 3-4% among the 
newborn boys. Before sex determination both female and 
male embryonic gonads are located in the same high 
abdominal position. The developing testes are migrating 
through a multiphase process of testicular descent (TD), first 
into low abdominal position and then into developing scrotum. 
Critical role in TD belongs to the proper differentiation and 
growth of gubernacular ligaments. Analysis of the mouse 
mutants revealed a number of genes involved in this process. 
INSL3 (insulin-like 3) is a peptide hormone of relaxin-insulin 
family, expressed in Leydig cells in testis. INSL3 signals 
through its cognate G protein-coupled receptor LGR8, which 
is expressed in gubernacular cells and controls the 
transabdominal phase of TD. The inguinoscrotal stage of TD 
is believed to be mediated mainly by androgens. Several 
transcription factors, such as Hoxal0, Hoxa11, and Desrt, 
caused cryptorchidism in mice, suggesting an involvement of 
additional signaling pathways in TD. Using different mouse 
transgenic lines we have analyzed the regulation and 
interactions between these genes. The mutation analysis of 
INSL3 and LGR8 genes in human patients with testicular 
matdescent revealed mutant alleles present exclusively in 
affected patients. A unique missense mutation (T222P) in the 
ectodomain of the LGR8 receptor has been identified 
exclusively in patient group in some populations. The 
expression analysis of the mutant protein revealed that the 
mutation severely compromised receptor cell membrane 
expression. Consecutively, we have also shown compromised 
physiological properties of the mutant I NSL3 variants identified 
previously in cryptorchid patients. Thus, mutations in the 
INSL3 and LGR8 genes might be responsible for the etiology 
of some cases of cryptorchidism in humans. 
S 09 
The role of chromatin in the establishment of 
paternal epigenetic information during 
spermatogenesis 
S 08 
Cryptorchidism - relaxins and other factors 
S. ROUSSEAUX, A.K. FAURE, J. THEVENON, 
E. ESCOFFIER, C. LESTRAT, J. GOVIN, S. HENNEBICQ, 
B. SELE, C. CARON, So KHOCHBIN 
Unit6 INSERM-UJF U309, 38706 La Tronche Cedex, 
France E-mail : sophie.rousseaux@ujf-grenoble, fr 
I. A. AGOULNIK 
Department of Obstetrics and Gynecology, Bay/or College 
of Medicine, Houston, Texas, 77030, USA 
Cryptorchidism is a one of the most frequent congenital 
It is now admitted that, in addition to genetic information, the 
spermatozoon conveys information, named "epigenetic", 
which is not encoded by the DNA sequence. Epigenetic 
information is known to be crucial for the development of the 
embryo. 
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In somatic cells, the epigenome conveys the epigenetic 
information, which is supported by the DNA methylation as 
well as by modifications of the genome packaging structures, 
or epigenome, which consists of the nucleosomal chromatin 
(DNA wrapped around somatic histones). 
During post-meiotic maturation of the male germinal cells, or 
spermiogenesis, the epigenome is completely re-organised 
since most somatic histones are replaced by sperm-specific 
basic proteins, the protamines, which are responsible for the 
tight compaction of the haploid genome within the sperm 
nucleus. 
Although this process has long been described, very little is 
known about the molecular events and factors involved. We 
have identified several chromatin modifiers, which could have 
a crucial role during post-meiotic hromatin re-organisation. 
Moreover, it is now known that the sperm genome is not 
uniformly packed with protamines, and that some histones 
remain, as well as some other non-histones, non-protamines 
basic proteins. Our recent data suggest that specific regions 
of the genome could be associated with specific structures 
within the sperm nucleus. 
The heterogeneity and specificity of this structure organising 
the sperm genome could convey specific paternal epigenetic 
information to the zygote, which could play a key role during 
development. 
Finally, the implications of these data in the field of male 
infertility will be discussed. 
spermatogonia. Germline inactivation of Rara results in a 
testicular degeneration comprising some, but not all, abnormal 
features observed upon dietary vitamin A deficiency, whereas 
germline inactivation of either Rarb or Rarg do not cause 
primary testicular defects. 
A selective ablation of the RAR(~ gene in mouse Sertoli cells 
(RaraSer-/- mutation) yields testis defects identical to those 
generated upon inactivation of RARc~ in the whole organism, 
indicating that all RARc~ functions in male reproduction are 
Sertoli cell-autonomous. During postnatal testis development, 
the RaraSer-/- mutation abolishes cyclical gene expression 
in Sertoli cells. It also induces testicular degeneration features, 
as well as a delay in spermatogonial Stra8 expression, two 
hallmarks of RA deficiency. Thus, our data demonstrate that 
RAR~ is a master regulator of the Sertoli cell cycle and plays 
important paracrine functions in spermatogonia differentiation 
and survival of germ cells. However, ablation of all three 
RARs in Sertoli cells does not induce an arrest in 
spermatogonia differentiation and does not abolish Stra8 
expression, as does vitamin A deficiency. These phenotypic 
differences point to a cooperation between distinct RA 
signalling pathways mediated by RAR~ in Sertoli cells and by 
RARy in spermatogonia during spermatogenesis. 
Additionally, ablation of all three RXR (c~, ~ and y isotypes) in 
Sertoli cells does not recapitulate the RaraSer-/- mutant 
phenotype, providing thereby the first evidence that RAR~ 
exerts functions in vivo independently of its heterodimerization 
with a RXR. 
$10 
Retinoic acid signalling in the testis 
M. MARK, N. VERNET, C. DENNEFELD, F. GUILLOU, P. 
CHAMBON, N.B. GHYSELINCK 
Institut de G~n~tique t de Biologie Mol~culaire et 
Cellulaire (IGBMC), 67404 IIIkirch Cedex, Communaute 
Urbaine de Strasbourg, France. 
Development and functioning of the mammalian seminiferous 
epithelium, require a complex assortment of hormones and 
cytokines. Amongst these, retinoic acid (RA), the active 
metabolite of vitamin A (retinol) regulates spermatogonia 
differentiation and spermatid adhesion properties. RA acts 
through binding to nuclear receptors, the Retinoic Acid 
Receptors (RARc~, ~ and y isotypes), which are ligand- 
dependent transcriptional regulators. In general, RAn 
transduce the RA signal in the form of heterodimers with 
Rexinoid Receptors, RXRc~, !3 and 7. Each RAn is detected 
in a specific cell-type of the seminiferous epithelium: RARo~ 
in Sertoli cells, RAR~ in round spermatids and RAn7 in A 
$11 
Connexins - relevance to rodent and human 
spermatogenesis 
M. BERGMANN 
Institute of Veterinary Anatomy, Histology & Embryology, 
Justus-Liebig-University, Giel~en, Germany 
Gap junctions contain channels that connect neighbouring cells 
and constitute the basis for direct intercellular communication 
via exchange of ions, second messengers and metabolites. 
Each channel consists of two hemichannels, called connexon, 
which are formed by the hexameric assembly of protein 
subunits, connexins (Cx), a familiy of highly related proteins, 
that consist of at least 21 members in human and 19 in 
rodents. In the testis, gap junctional intercellular communication 
is well known between interstitial Leydig cells and endothelia 
of blood vessels, and within the seminiferous epithelium 
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between Sertoli cells, and between Sertoli cells and germ 
cells. 
In rodent testis, six isoforms have been demonstrated so far. 
Cx37 was solely found in blood vessel endothelia, while Sertoli 
cells express Cx 26, Cx32, Cx33, and Cx43. Germ cells are 
positive for Cx31 and Cx 43. In the testis, Cx 43 seems to be 
the most important and predominant connexon. In the 
seminiferous epithelium, it is first expressed together with 
the pubertal terminal differentiation of Sertoli cells and it's 
expression depends on the seminiferous epithelial cycle. The 
importance of Cx 43 to gametogenesis in indicated by severe 
depletion of germ cells in prenatal male and female mice 
lacking the Cx43 gene. Postnatal spermatogonial proliferation 
is impaired in Cx43-null mutants, and this defect can not be 
restored by insertion of Cx32 or Cx 40 coding regions into 
the respective region of Cx43-/- mice. It is impossible to 
evaluate the physiological role of Cx 43 or Cx 26 by knockout 
mouse models, because Cx43 knockout leads to altered 
cardiac morphology and perinatal death, and Cx 26 deficient 
mice die on embryonic day 11 because of placental deficiency. 
In order to circumvent perinatal ethality and pleiotropic effects, 
we generated a mouse line that carries the floxed connexin 
43 coding region flanked by IoxP recognition sites for the Cre 
recombinase. Sertoli cell specific deletion was achieved by 
crossing these floxed mice with mice harbouring the transgene 
under control of Sertoli cell specific AMH gene. First data 
show, that these Sertoli cell specific Cx 43 knockout mice 
show a prepubertal arrest of spermatogenesis at the level of 
spermatogonia indicating, that Cx43 expression plays the 
key role in the initiation of spermatogenesis, which is not 
replaced by the up-regulation of other Cx's. Cx26 seems to 
be restricted in the apical region of rodent seminiferous 
epithelium, i.e. in spermatids and/or Sertoli cells. Cx 33 is a 
member of the gap junction showing several specialities. In 
contrast o most other Cx's which are also expressed in other 
tissues, Cx 33 expression seems to be restricted only to the 
testis. It was shown to inhibit the expression of Cx33 and to 
reduce Cx43. Its functional role is believed to limit the capacity 
of cells to create functional channels by enabling formation 
of heterotypic channels with other cells. The Cx33 gene, 
which is mapped to the X chromosome in the rat and mouse 
genome has no orthologs in the genome of humans or any 
other mammals, such as dog, cattle, pig, horse, and marmoset 
monkey, which have been investigated so far. 
In the human Cx43 and Cx26 expression was intensely 
investigated. As in rodents, Cx43 is firstly found during pubertal 
Sertoli cell terminal differentiation and shows stage dependent 
expression in adult normal seminiferous epithelium. Cx26 is 
weekly expressed and located at inter Sertoli cell junctional 
sites. Both Cx's have been found to be functional Sertoli cell 
markers, indicating the state of Sertoli cell differentiation in 
testes of infertile patients showing spermatogenic impairment. 
Sertoli cells in seminiferous tubules showing an arrest of the 
seminiferous epithelium reveal a persistant AMH expression 
together with an abberant diffuse cytoplasmic Cx26 staining, 
and absence of Cx43 expression indicating a prepubertal 
state of Sertoli cell population without functional intercellular 
communication. This is also true for Sertoli cells associated 
with preinvasive testicular intraepithelial neoplasia (TIN), syn. 
: Carcinoma in situ (CIS) which is known to be the precursor 
of germ cell tumours such as seminomas and non seminomas 
with the exception of spermatocytic seminoma. In TIN tubules 
Sertoli cells show a progressive down-regulation of Cx43 
indication the loss of intercellar communication between 
Sertoli cells and between Sertoti cells and preinvasive tumor 
cells. Aberrant gap junctional intercellular communication 
and/or loss of connexin expression has been demonstrated 
to correlate with neoplastic transformation in several human 
tissues such as prostate, breast, lung, and brain. Thus the loss 
of gap junctional intercellular communication might lead to 
uncontrolled mitotic division of CIS cells and finally to solid 
invasive neoplasia. 
References 
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Databases and data mining in studies on 
spermatogenesis 
M. PRIMIG 
Biozentrum & Swiss Institute of Bioinformatics, 
Klingelbergstrasse 50 -70, 4056 Basel Switzerland 
Email : marek@titus, u-strasbg, fr 
No abstract provided. 
$13 
Human epididymal proteins: regulation and 
interactions with spermatozoa 
R. SULLIVAN 
Centre de Recherche en Biologie de la Reproduction and 
D#pt Obstetrique-Gyn#cologie, Universit~ Laval, Canada 
robert.sullivan@crchuL ulaval, ca 
Vasectomy is the third most common contraceptive method 
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and the demand for surgical vasectomy reversal 
(vasovasostomy) is increasing. Some consequences of 
vasectomy on human epididymal physiology will be presented. 
Vasectomy disturbs gene expression in the human epididymis. 
Vasectomy modifies the pattern of expression of P34H, a 
protein expressed in the human corpus epididymidis, added 
to the sperm surface during maturation and involved in zona 
pellucida binding. While P34H is expressed in the corpus 
epididymidis in normal men, its expression is restricted to the 
proximal caput epididymidis. This may affect the fertilizing 
potential of ejaculated spermatozoa of some 
vasovasostomized men. 
In fact, an important proportion of vasovasostomized men 
are characterized by spermatozoa lacking the P34H protein. 
Although the expression of P34H in the epididymis is relocated 
under vasectomy, HE1/NPC2, a gene expressed all along 
the human epididymis, is down-regulated under vasectomy. 
Westerm blot analyses show that many vasovasostomized 
men are characterized by high HE1/NPC2 levels on 
spermatozoa when compared to fertile donors. HE1/NPC2 
association with sperm from vasovasostomized men is not 
correlated to low motility per se as spermatozoa from 
asthenospermic men have similar levels of HE1/NPC2 as in 
normal fertile semen samples. Spermatozoa from 
vasovasostomized men with high amount of HE1/NPC2 are 
characterized by higher concentration of cholesterol and more 
lipid raft domains. Knowing the effect of cholesterol on sperm 
physiology, this may affect the fertilizing ability of the male 
gametes. HE1/NPC2 is secreted in different glycoforms by 
different tissues of human male reproductive tract. These 
forms are due to variation in N-glycosylation and only the 
deglycosylated form is associated with spermatozoa from 
some vasovasostomized men. 
Compared to normal men, seminal plasma of vasectomized 
men is characterized by a major decrease in immunodetectable 
HE1/NPC2 without change in the glycosylation pattern. 
Following surgical vasectomy reversal, seminal plasma 
HE1/NPC2 is found in similar amount to the ones 
characterizing normal men. Considering the potential role of 
HEI/NPC2 in cholesterol transport during sperm maturation, 
unusual high levels of this protein associated with spermatozoa 
of vasovasostomized men may reflect epididymal sequelae 
occurring when the vas deferens is obstructed. Taken together, 
our results show that vasectomy affects gene expression 
along the human epididymis. These changes have 
consequences on some biochemical characteristics of 
ejaculated spermatozoa of vasovasostomized men. Thus, 
sequelae to the human epididymis under vasectomy may not 
be reversible in all men following vasovasostomy. This may 
explain the discrepancy between surgical success of vas 
deferens reanastomosis and fertility recovery. 
This work was supported by CIHR (Canada). 
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Human epididymal proteins - secretion, 
absorption, and luminal fluid composition 
J-L. DACHEUX 
Equipe "Gametes M&les et FertilitY", UMR 6175 INRA- 
CNRS-Universite de Tours-Haras Nationaux, Physiologie 
de la Reproduction et des Comportements, 37380 Nouzilly, 
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No abstract provided. 
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Sperm membrane dynamics : structure and 
function 
R. JONES 
The Babraham Institute, Cambridge CB2 4AT, UK 
roy.jones@bbsrc, ac. uk 
Sperm plasma membranes are unusual for their high content 
of unsaturated phospholipids and their compartmentalisation 
into at least 5 recognizable domains, each with specific and 
overlapping lipids and glycoproteins. Elucidating how these 
domains are created and maintained over relatively large 
distances against the randomising forces of diffusion is central 
to understanding membrane remodelling events during sperm 
maturation and capacitation. Foremost amongst remodelling 
processes is repositioning of specific components from areas 
of the spermatozoon where they are 'inactive' to regions 
where they become 'active', either as a result of processing 
(e.g. endoproteolysis) or because they form complexes (e.g. 
lipid rafts) with new membrane components. 
To understand the supramolecular structure of the sperm's 
plasma membrane we have applied a range of quantitative, 
high resolution microscopy techniques to investigate the 
dynamics of lipid and protein diffusion in live spermatozoa 
(boar, ram, bull and mouse) at different stages of development. 
The methods include atomic force microscopy (AFM), scanning 
ion conductance microscopy (SICM), fluorescence recovery 
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after photobleaching (FRAP), fluorescence loss in 
photobleaching (FLIP), single particle fluorescence imaging 
(SPFI) and single molecule tracking (SMT). AFM revealed 
significant differences in membrane topography between the 
acrosome, postacrosome and identified a new region within 
the equatorial segment, designated the subsegment (EqSS). 
The EqSS is enriched in Hsp70 and constitutively 
phosphorylated proteins and is assembled during epididymal 
maturation. 
FRAP analysis using lipid reporter probes demonstrated 
significant differences between the sperm head and tail 
domains that, surprisingly, were largely unaffected by lipid 
peroxidation from oxygen free radicals. Combined FLIP and 
SPFI analysis suggested the presence of a molecular 'filter' 
rather than an absolute diffusion barrier between the acrosomal 
and postacrosmal domains. This has been substantiated by 
SMT although the nature of the probe and target molecule has 
to be taken into account. Thus, sperm membranes can respond 
rapidly to agonists in external fluids, be they in the epididymis 
or female reproductive tract or artificial media, by remodelling 
the composition of specific membrane domains and by 
assembly/disassembly of multimolecular complexes that 
transduce signals across the membrane. This hierarchy of 
responses at each stage of maturation and capacitation 
ensures that only fully competent spermatozoa reach the site 
of fertilization in vivo. 
This work was supported by the BBSRC, UK. 
of Ca2+-fluxes at the plasma membrane is essential for 
activation of acrosome reaction upon binding of the zona 
peUucida and for chemotactic responses mediated through the 
olfactory receptors that have recently been found in human 
sperm. 
In contrast, progesterone apparently regulates motility by 
controlling mobilisation of Ca 2+ stored inside the cell. It has 
become clear that sperm show surprising sophistication in their 
ability to generate complex spatio-temporal [Ca2+]i signals 
and use them discretely to regulate the different activities of 
the cell, control their 'behaviour' and maximise their chance 
of Success. 
Significant progress in understanding the functioning of sperm 
and the way in which their activities are regulated opens up 
new possibilities for studying fertilisation, for treating male 
sub-fertility and for development of new contraceptive 
strategies. 
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Sperm calcium signalling - nature and function 
S. PUBLICOVER 
School of Biosciences, University of Birmingham, UK 
Prior to fertilisation a human sperm must complete a series 
of tasks in order both to reach the egg and to be competent 
to fertilise when it arrives. These functions must be activated 
discretely and must be timed appropriately. They are 
dependent entirely upon 2nd messenger signalling, particularly 
[Ca2+]i. Compared to somatic cells, spermatozoa appear 
extremely simple, reduced to only those components 
necessary to achieve their single, specific purpose. 
However, recent studies have transformed our understanding, 
revealing the spermatozoon to be a complex, highly-organised 
and tightly-regulated cell. Sperm express their own, apparently 
unique, 'toolkit' of Ca2+ homeostatic mechanisms. Regulation 
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Pathogenesis and diagnosis of premature 
ejaculation 
F. LOMBARDO 
Department of Medical Pathophysio/ogy, University of 
Rome "La Sapienza', Rome,/ta/y 
Premature ejaculation (PE) is a symptom rather than a disease. 
In fact, it can be caused by short frenulum of the prepuce, 
penile hypersensitivity and reflex hyperexcitability, prostatitis 
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and thyroid hyperfunction. Some researchers believe that PE 
is not a psychological disorder but a neurobiological 
phenomenon. This is a very interesting pathophysiological 
explanation, based on the role of serotoninergic system in the 
control of ejaculation. As a matter of fact, the effectiveness 
of serotoninergic antidepressants demonstrates that central 
neurotransmission is involved in ejaculatory control, but not 
that serotonin hypoactivity is the cause of PE, as suggested. 
In fact, many psychological disturbances provoke a 
neuroendocrine imbalance. 
On the other hand, the classic psycho-sexological approach 
affirms apodictically that PE is a psychosexual disorder, which 
is 'all in the mind' with a psychogenic aetiology and 
pathogenesis that must be treated with psychotherapy. 
The possibility that PE may involve marital problems should 
always be considered, even though it may be difficult to 
discern whether the couple's troubles are the cause or the 
effect of PE. Whenever possible, sexual symptoms should be 
assessed in the context of the couple. For this reason, it is 
essential to compare the male's description of the symptom 
with that of his partner. Perception of penetration time is in 
fact very subjective. 
The physical examination of the patient with PE is usually 
normal: pathological findings are unlikely to be associated 
with this condition. However, penile biothesiometric 
measurement of the penile shaft, the glans penis and the 
mid scrotum has been proposed as a useful method to 
evaluate and qualify penis sensitivity, but denied by others. 
The biothesiometer is a vibrating device with a fixed frequency 
of 50 Hz and variable amplitude which is placed on these 
genital areas. The patient is asked to inform the examiner of 
the first sensation of vibration as the amplitude is slowly 
increased. 
A possible flow chart of PE diagnosis is proposed. It should 
include prostate evaluation by transrectal ultrasonography 
and standardized Meares & Stamey protocol (1968). Urethral 
and midstream bladder urine, expressed prostate secretions 
by prostate massage, and post-massage urine samples are 
collected, examined microscopically, and cultured 
bacteriologically. Prostate inflammation is diagnosed if 10 or 
more white blood cells per high power field are present in the 
expressed prostate secretions. Non-bacterial prostatitis is 
defined by evidence of prostate inflammation together with 
negative urine and prostate fluid cultures. Prostate infection 
is defined by a colony count 10 times greater in the expressed 
prostate secretion or post-massage urine sample than in the 
urethral urine sample. The presence of Chlamydia 
Trachomatis, Trichomonas vaginalis, Mycoplasma hominis, 
Candida species, and Ureaplasma urealyticum should be 
carefully checked. 
Negative subjects should be further studied for the possible 
presence of hyperthyroidism and, in selected cases, 
neurological diseases. 
$19 
Management of premature ejaculation 
S. DROUPY 
Dept of Urology, Academic Hospital of Bicetre, 78 Rue du 
General Leclerc, 94270 Le Kremlin-Bicetre, France 
Email : stephane.droupy@bct.ap-hop-paris.fr 
No abstract provided. 
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Antiviral defences of the testis 
N. DEJUCQ-RAINSFORD 
GERHM-INSERM U. 625 Universite de Rennes 1, - 
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France 
Viral infection of the testis can have damaging consequences 
for the fertility and general health of the individual : it may 
disrupt he reproductive and endocrine functions, as illustrated 
by mumps virus and HIV infection in human, and potentially 
lead to testicular cancer (although the latter remains to be 
formally proven). It may also participate to the spreading of 
viruses from host to host through contaminated semen. 
Moreover, viral infection of the germ cells may result in the 
transmission of virus-induced mutations to subsequent 
generations. 
Acquired immune reactions are normally suppressed in the 
testis in order to prevent germ cells destruction. We seek 
whether the testis possesses innate defense mechanisms to 
counteract viral attack and limit harmful infiltrations of 
specialized immune cells. Our research was initiated in the 
rat since there are no documented viral infections of the testis 
in this animal. Interferons (IFNs), discovered through their 
ability to "interfere" with viral replication, represent the main 
component of the cell antiviral response. These cytokines 
act in an autocrine/paracrine manner by inducing the 
expression of various proteins (the so-called IFN-induced 
proteins), the three best characterized in term of antiviral 
activity being the 2'5' oligoadenylate synthetase (25OAS), 
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the double strand RNA activated protein kinase PKR and the 
Mx proteins. IFNs and IFN-induced proteins expression was 
investigated in different rat testicular cell types in both basal 
conditions and following in vitro viral stimulation (Sendai virus, 
an RNA virus of the paramyxovirus family). The protection of 
the germ cells in the seminiferous tubules is of prime 
importance because their infection may result in the total 
destruction of the germ line or the dissemination of the virus 
or viral DNAto all germ cell classes, including the spermatozoa 
themselves. Spermatogonia are one of the most important 
potential targets because unlike the meiotic and postmeiotic 
germ cells, they are not isolated from the molecules and 
agents produced by the interstitial compartment. 
The basal tubular position of these germ line precursors, a 
priori, exposes them to the risk of contamination in cases of 
viral infection. Despite the high potential risk of infection of 
spermatogonia, these cells do not constitutively express 
biologically active IFNs and they respond only weakly to 
stimulation by the Sendai virus in vitro. Moreover, they only 
weakly express the antiviral protein Mx and do not express 
2'5'AS or PKR. Similarly, early spermatids and pachytene 
spermatocytes, although expressing low levels of IFNs in 
basal conditions, respond very weakly if at all to exposure to 
the Sendai virus and do not produce any of the 3 IFN-induced 
antiviral proteins tested (2'5'AS, PKR and Mx). 
It was therefore suggested that the germ cell antiviral protection 
system may involve mainly the somatic peritubular and Sertoli 
cells within the seminiferous tubules and the somatic Leydig 
cells and macrophages within the interstitium, all of which 
have subsequently been shown to express both high levels 
of IFNs and IFN-induced proteins in response to viral infection. 
Of all the testicular cell types tested, Leydig cells and Sertoli 
cells have by far the strongest antiviral potential. Thus, in the 
rat testis, a first line of defense against viruses arriving in the 
bloodstream is represented by Leydig cells and testicular 
macrophages, whilst a second line of defense involves the 
myoid cells lining the seminiferous tubules and Sertoli cells. 
However, the situation may vary in between species as the 
first results obtained in human Leydig cells show lack of IFN 
production when exposed to a range of viral stimuli, including 
mumps virus and the RNA virus-like, synthetic double strand 
RNA poly IC. Despite this, virally stimulated Leydig cells over- 
express two antiviral proteins, the 25OAS and MxA protein. 
To fully apprehend the innate immune status of the human 
testis, the antiviral capabilities of all testicular cell types will 
need to be tested. 
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Most sexually transmitted viruses can also be found in male 
or female genital secretions and detected by cell culture or 
genomics. HBV, HSV, CMV, HHV-8, HPV, HTLV and HIV 
have been studied in human semen. Some other viruses can 
be detected in semen using new improved molecular biology 
techniques, but they are poorly transmitted during sexual 
intercourse. This is particularly true for HCV. Many other 
viruses that are probably non-pathogenic may be detected in 
semen. All viruses involved in viremia or associated with white 
blood cells can be, at least in theory, present in semen. 
The viruses in semen, can be present as free virus particles 
in the semen plasma, as infected cells (with productive or 
latent infections), and in the spermatozoa themselves. The 
spermatozoa are unlikely to harbour productive infections, 
but they may have latent infections and virus reactivation 
cannot be excluded. This has been shown for human 
endogenous retroviruses (HERV) and remains a discussed 
possibility for HBV. The infected cells are usually lymphocytes, 
monocytes or polymorphonuclear cells. An increase risk of virus 
shedding is associated with the presence of these cells in 
semen and when there is genital inflammation or infection. 
Free virus particles in the semen can come from the blood 
by passive diffusion during the viremia phase of infection or 
from local virus replication. The characteristics (genome 
sequence) of virus produced by local replication in semen 
are often different from those of viruses in the blood, reflecting 
compartmentation. 
Semen is screened to detect viruses with pathogenic potential 
so as to limit sexual transmission and the risk of transmission 
during medically assisted procreation (MAP). Screening is 
based on virus acquisition risk factors, clinical signs, systematic 
or oriented biological screening. Vaccines, when available, are 
then used to avoid transmission to the partner. Antiviral 
treatments are becoming more and more efficient and can cure 
a patient by eradicating virus from his/her body in some cases 
(HCV for example). But they usually only limit virus replication 
or keep it below the level needed to control clinical evolution. 
These antiviral treatments can reduce the virus concentration 
in the semen and thus the risk of transmission, depending on 
their ability to diffuse into the male genital tract. The assays 
used to detect virus in semen have improved greatly in recent 
years and are now very sensitive and less influenced by 
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semen PCR inhibitors. However, a negative result does not 
mean that virus is absent, since there is always a detection 
threshold in all assays of virus genomes. 
Sperm processing techniques can further decrease the risk 
of transmission from patients that may have residual virus in 
their semen (eg. HIV) by eliminating semen plasma and non- 
spermatozoa cells and by keeping only spermatozoa for MAP. 
These methods have proved to be effective for treating semen 
containing HIV-1 and HCV and should be just as effective for 
removing other viruses. 
Nevertheless, the way many viruses are shed into the semen 
has not yet been characterized, especially during incubation 
phase or when the infection is asymptomatic or acute. This 
should be taken into account in the future management of the 
risk of transmission of viral diseases. 
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The development of highly active antiretroviral therapy 
(HAART) over the last 10 years has transformed the prognosis 
of patients infected with human immunodeficiency virus type- 
1 (HIV) living in the developed world. HIV has been reclassified 
as a chronic disease with good life expectancy and quality and 
many heterosexual couples, where one or both partners are 
infected, are now considering parenting as a realistic option 
In a heterosexual couple where the male partner is infected, 
unprotected intercourse caries a risk of transmitting HIV to the 
uninfected female partner and potential child of 0.1% per act 
of intercourse. Unfortunately viral load in semen correlates 
poorly with that in serum and men on antiretroviral medication 
with undetectable viral loads can still have detectable virus 
present in semen. 
Sperm washing is a specific risk-reduction option available to 
HIV serodiscordant couples where the male is infected trying 
to conceive. Semen is centrifuged in a density gradient to 
separate live sperm, which does not carry HIV, from seminal 
plasma and non-germinal cells which may carry virus and 
then inseminated into the female partner at the time of 
ovulation. If a couple have additional fertility issues, sperm 
washing can be combined with ovulation induction, in vitro 
fertilisation (IVF) or intracytoplasmic sperm injection (ICSI). 
In order to ensure the final preparation used in clinical practice 
is free of HIV and safe to use, an aliquot of washed sperm is 
tested for detectable HIV RNA prior to the sample being used 
for treatment. A nucleic acid-based sequence amplification 
(NASBA) or similar commercial PCR assay can be used. 
The clinical program for sperm washing at The Chelsea and 
Westminster Hospital was established in 1999 and has 
performed the largest series on treatments in the UK. 106 
couples have undergone 293 cycles of IUI with a live 
birth/ongoing pregnancy rate per cycle of 10.2% and clinical 
pregnancy rate of 14.3%. These figures are similar to national 
statistics for IUI using donor sperm and compare favourably 
to results reported from other centres in Europe with similar 
programs for serodiscordant couples. In terms of safety, there 
have been no seroconversions in either female partner or 
child on rigorous follow-up (HIV testing of female partner for 
up to 6 months after the last treatment with washed sperm) 
and 27 healthy children have been born to date through the 
IUI program alone (45 through the sperm washing program 
including IVF and ICSI cases). In our series, the cancellation 
rate due to a positive NASBA post wash was 3.3%. 
Semen samples from 106 HIV-positive men undergoing sperm 
washing IUI weer compared with those from a control group 
of 234 HIV-negative men undergoing IUI (Nicopoullos et al., 
2004). Markers of HIV were assessed and although the 
majority of HIV-positive men had sperm parameters within the 
defined WHO 'normal' range, ejaculate volume, sperm 
concentration, total count, progressive motility and normal 
morphology were all significantly lower in the HIV-positive 
group compared to the HIV-negative controls (p < 0.05). There 
was a significant positive correlation between CD4 count and 
sperm concentration, total count and total and progressive 
motility and a significant negative correlation with normal 
sperm morphology of both raw and post preparation samples. 
There was no correlation between viral load, years since 
diagnosis, use of or duration of use of HAART with any semen 
parameter. This is the largest analysis of semen parameters 
in HIV-positive men to date. 
We also analysed the factors which had an impact on IUI 
outcome in our first 140 cycles of IUI with sperm washing. 
Clinical pregnancy rate was significantly higher in cycles 
where the man had a low viral load (<1000copies/ml; 29% 
versus 11%, p=0.05) and in cycles where the man was on 
HAART (27% versus 9%, p=0.02).CD4 count had no impact 
on IUI outcome. Although these data clarify the factors that 
influence IUI outcome, they do not shed light on the precise 
mechanism by which HIV and markers of HIV infection alter 
semen parameters and IUI outcome which should be the 
subject of further investigation. Our present advice is that the 
decision to start or stop medication should be not be based 
on concern for fertility but rest primarily on viral load and CD4 
count parameters and health of the individual. 
Further reading 
Gilling-Smith C., Nicopoullos J.D., Semprini A.E., 
Frodsham L.C. : HIV and reproductive care - a review of 
current practice. B JOG. 2006, 113(8) : 869-878. 
Frodsham L.C.G., Boag F., Barton S., Gilling-Smith C. : 
Human immunodeficiency virus infection and fertility care 
in the United Kingdom - demand and supply. Fert. Stedl., 
2006, 85 : 285-289. 
Nicopoullos J.D.M., Ramsay J.W.A., Almeida P.A., Gilling- 
Smith C. : The effect of HIV on sperm parameters and the 
outcome of IUI following sperm-washing. Hum. Reprod., 
2004, 19 : 2289-2297. 
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The field of bacterial infection and sperm quality, stagnant for 
at least three decades, has changed from the nineties years. 
Two different panel of scientists evaluated this research area 
ending up with two independent consensus conferences. The 
first, of mainly urological background (NIH Chronic Prostatitis 
Collaborative Research Network), focused on prostatitis 
classification and only two categories (11 and IV) were 
associated with male infertility (Krieger et al., 1999; Nickel et 
al., 2001). Sperm analysis was included among the optional 
tests and therefore it does not play a pivotal role. This justifies 
the contradictory data available on the influence of urogenital 
tract infection on sperm quality with a full array of effects 
reported which range from a negative impact on all main 
sperm parameters (density, motility and morphology) or on 
sperm motility only, to no sperm parameter alteration at all (see 
Weidner et al., 1999, for review). 
The second task force, of uro-andrologic background (WHO 
Task Force on the Diagnosis and Treatment of Infertility (WHO, 
1993), identified a diagnostic category affecting male 
reproductive function and fertility which was named male 
accessory gland infection (MAGI). In this classification, sperm 
analysis is viewed as a fundamental step of the diagnostic 
workup. In fact, MAGI is diagnosed in presence of one or 
more sperm parameter abnormalities (oligo- or astheno or 
teratozoospermia) associated with a combination of two or 
more of the following factors : 
- Factor A : history positive for urinary tract infections and/or 
sexually-transmitted iseases and/or physical urogenital 
examination ;
- Factor B : expressed prostate signs of infection and/or 
inflammation ;
- Factor C : ejaculate signs of infection. 
According to the NIH classification, seminal bacterial infection, 
corresponding to chronic bacterial prostatitis (category II, NIH 
classification), has a marginal epidemiologic role since bacterial 
prostatitis (acute or chronic) accounts for a low number of 
patients with prostate symptoms (5-10%) (see Weidner et 
al., 1999, for review). Recently, Li and colleagues reported a 
higher rate of bacterial infection (24.2%) in patients with 
prostatitis type IV (Li et al., 2004). On the contrary, MAGI has 
been reported to account for a wide range of frequency (1.6- 
39.1%) of infertile patients according to the various infertility 
clinic settings (Comhaire et al., 1986; Andree6en et al., 1993; 
Vicari, 2000; Diemer et al., 2003; Li et al., 2004). 
In the course of urogenital bacterial infection, sperm quality 
is the final product of germ intrinsic properties (degree of 
virulence, bacterial load), time of interaction the microorganism 
and the involvement of one or more sex accessory glands. 
Some Gram Enterobacteriaceae, such as Escherichia coli, 
Klebsiella sp., Proteus, Serratia, Pseudomonas sp, etc., have 
been recognized as known prostate pathogens (category II, 
NIH classification) having a strong association with a clear 
positive clinical history (prior and/or recurrent urinary tract 
infection, sexually transmitted isease, congenital uro-genital 
abnormalities) and some uro-genital abnormalities at the 
physical examination. On the other hand, the only presence 
of some microrganisms is interpreted by some investigators 
as "probable" (when Gram-positive pathogens, such as 
Enterococcus sp, and Staphylococcus aureus, are present) 
or "possible" (when coagulase negative pathogens, such as 
Staphylococcus, Chlamydia, Ureaplasma, anaerobes are 
present) prostate infection. The major difficulty in interpreting 
microbiological findings is the presence of contaminating, 
indigenous microbiota, or of inhibitory substances known to 
be present in the prostatic secretions, as well as previous 
courses of antibiotics. Thus, the diagnosis of bacterial prostatitis 
may be confirmed by quantitative bacteriological cultures in 
the semen (growth of > 103 pathogenic bacteria or > 104 non- 
pathogenic bacteria in seminal plasma diluted 1:2 with saline 
solution) (Comhaire et al., 1980) or segmented cultures, i.e. 
four (Meares and Stamey, 1968) and/or two (Nickel, 1997) 
glass test. 
In addition, underlying prostate and systemic chronic 
comorbids have to be taken into account. Thus a negative 
impact on sperm quality may arise from one (or more) of the 
following mechanisms: 1) secretory dysfunction of one or 
more male accessory glands; 2) deterioration of 
spermatogenesis; and 3) (unilateral or bilateral) organic or 
functional sub-obstruction of the seminal tract. Gland secretory 
dysfunction represents the most relevant cause of negative 
impact of sperm quality. It induces an inflammatory response 
(leukocytospermia, reactive oxygen species and/or cytokines 
release, such as IL-II3, IL-6, IL-8, TNFc~; and autoimmune 
processes) (Ochsendorf, 1999; Vicari, 2000; Vicari & Calogero, 
2001 ; Weidner et al., 2002; Vicari et al., 2002; Diemer et al., 
2003). These bioactive substances may persist even following 
successful treatment with antimicrobials, since the initial 
antioxidant capacity (mainly based on epididymal biological 
micronutrients of the seminal plasma) is progressively 
exhausted, thereby impairing sperm function by inducing 
DNA damage and/or apoptosis (Agarwal et al., 2003; Sanocka 
et al., 2003). Gland structural abnormalities may, in addition, 
play a negative role. In fact, infertile patients with MAGI and 
elevated bacteriospermia (>105 CFU/ml) or with Clamydia or 
Ureaplasma urealitycum infection (at urethral swabs after 
prostate massage) have a higher number of ultrasonographyc 
abnormalities involving more glands (prostato-vesiculo- 
epididymitis, epididymo-orchitis) (Vicari, 1999; Vicari et al., 
2006). These patients show also to have an increased 
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inflammatory response and an impaired semen quality directly 
related to MAGI extension (prostatitis < prostato-vesiculitis < 
prostato-vesiculo-epididymitis) (Vicari, 1999) or a strong 
association with sperm abnormality (Bayasgalan et al., 2004). 
In conclusion, sperm parameters represent the "end-target" 
of many possible pathophysiological mechanisms which may 
contribute to the onset of infertility related to urogenital 
infections. Therefore, despite an open debate with pros and 
cons on the role of MAGI in male infertility is going on, the 
andrologist should at least consider MAGI as a risk factor of 
male infertility (Bayasgalan et al., 2004), different from one 
country to another. Thus, MAGI may be or may become an 
effective cause of male infertility throu the above-mentioned 
multiple pathophysiological mechanisms which in turn impair 
sperm function. 
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